Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Denise Merle will retire as Senior Vice President and Chief Administration Officer effective December 31, 2026. She will be succeeded by Cristin Aragon, appointed as SVP and Chief Human Resources Officer, and Justin Nikbakhsh, appointed as SVP of Technology and Procurement, both effective January 1, 2027. Merle will remain as a strategic advisor during the transition period.
Vertex Pharmaceuticals EVP, Co & Fo Charles F. Wagner Jr. Sells $8.37M of Stock
Charles F. Wagner Jr., EVP, Co & Fo, sold 15,286 shares of Vertex Pharmaceuticals Inc at $547.87 a share, worth $8.37M in total on Nov 12, 2026. Shares held after the trade: 31,764 (-32.5%).
UDR, Inc. filed formal presentation materials to be made available to investors starting November 16, 2026. The filing was made under Item 7.01 (Regulation FD Disclosure) and includes an exhibit of the presentation materials.
Aethlon Medical M&A Deal with North Immunology, Inc.
Aethlon Medical provided a status update on its pending merger with North Immunology, Inc., originally announced on September 17, 2026. The filing includes an updated investor presentation that North Immunology will use in meetings with investors regarding the transaction and a concurrent private placement.
Sonic Automotive $850M Debt Financing with PNC Bank, National Association
Sonic Automotive entered into a $850 million Consolidated, Amended and Restated Credit Agreement with PNC Bank to consolidate and refinance its existing mortgage and sidecar debt facilities. The new facility consists of a $750 million term loan and a $100 million revolving credit facility, both maturing on November 10, 2031. The company immediately borrowed the full $750 million under the term loan facility on the closing date.
Hyperscale Data announced preliminary unaudited revenue of approximately $44.8 million for the third quarter of 2026, an 84% increase year-over-year. The company provided this update ahead of its formal earnings announcement and scheduled Investor Day on November 23, 2026. The results exceeded the company's previous estimate of $40 million for the period.
Invitation Homes Inc. filed a formal investor presentation for meetings in November 2026, highlighting its capital allocation strategy and portfolio performance. The company disclosed it has repurchased $1.0 billion of its stock since December 2025, funded primarily by home sales in high-value markets like Southern California and South Florida. The presentation also reaffirmed October 2026 leasing stats, showing 96.1% occupancy and 2.2% blended rental rate growth.
Precision Optics reported Q1 2027 revenue growth of 22% year-over-year to $8.2 million, driven by strong performance in satellite optical communications and single-use medical device programs. The company's net loss narrowed significantly to $0.5 million compared to $1.6 million in the prior year, while gross margins improved to 22.5%.
Term
Q1 2027
“Revenue grew 22% year over year to $8.2 million, led by a 23% increase in production revenue. Higher volumes and more efficient manufacturing helped lift gross margin and improved our Adjusted EBITDA.”
Dr. Joe Forkey, CEO of Precision Optics
“We continued to make operational progress with our single-use medical device programs. The cystoscope program generated $1.8 million in production revenue, and our ophthalmic program delivered revenue of $581,000, as shipments increased under its $3.5 million follow-on order.”
Robert J. Martsching resigned as Vice President, Corporate Controller, and principal accounting officer effective November 9, 2026. The Board appointed Sarah R. Nickless, previously the Director of Financial Planning & Analysis, to succeed him in these roles. Mr. Martsching will remain with the company through January 2027 to assist with the financial integration of the pending acquisition of Advanced Medical Solutions Group plc.
Conexeu Sciences Inc. has scheduled a Special Meeting of Stockholders for January 26, 2027, in Vancouver, Canada. The company established December 8, 2026, as the record date for stockholders entitled to notice and voting rights at the meeting.
Vivani Medical entered into a share purchase agreement for a $5.1 million private placement of common stock with board members Gregg Williams and Aaron Mendelsohn. The shares were priced at $1.01 per share, representing an at-the-market transaction based on the prior trading day's close. Proceeds will be used to fund the clinical development of NPM-139, the company's semaglutide implant for weight maintenance.
DeFi Development Corp. declared daily cash dividends of $0.00530 per share on its Variable Rate Series C Perpetual Preferred Stock (CHAD) for the month of December 2026. The dividends will be paid for 22 business days, totaling approximately $186,707 in aggregate, representing a 14.00% per annum dividend rate. The company noted that these distributions are expected to be treated as a tax-free return of capital as it does not expect to generate earnings and profits in the foreseeable future.
Standard Biotools M&A Deal with Treeline Biosciences, Inc.
Standard BioTools Inc. provided a status update regarding its pending acquisition of Treeline Biosciences, Inc., specifically addressing stockholder litigation and demand letters. To avoid potential business delays and moot disclosure claims, the company issued supplemental disclosures to its definitive proxy statement ahead of the special meeting of stockholders scheduled for November 19, 2026.
Celanese Corporation has elected Peter Matt to its Board of Directors, increasing the board size from 11 to 12 members. Mr. Matt currently serves as the President and CEO of Commercial Metals Company and brings over 40 years of experience in finance and global manufacturing leadership. He is expected to stand for re-election at the company's 2027 Annual Meeting of Shareholders.
Jason Kruger resigned as Chief Financial Officer, principal financial officer, and principal accounting officer effective November 10, 2026. In response, the Board appointed President and CEO Yuichi Iwaki to serve as interim CFO and acting principal financial/accounting officer until a successor is named. Dr. Iwaki will not receive additional compensation for the interim role.
Dror Ortho-Design, Inc. reported a net loss of $1,784,697 for the nine months ended September 30, 2026, compared to $1,988,989 in the prior year period. The company remains in the research and development stage with no revenue, and management has expressed substantial doubt about its ability to continue as a going concern due to an accumulated deficit of $23.8 million and negative working capital.
Third Coast Bancshares Insider Bart Caraway Buys $24.9K of Stock
Bart Caraway bought 638 shares of Third Coast Bancshares, Inc. at $39.02 a share, worth $24.9K in total on Nov 16, 2026. Shares held after the trade: 164,798 (+0.4%).
Onespaworld Holdings President, CFO and COO Stephen Lazarus Sells $5.36M of Stock
Stephen Lazarus, President, CFO and COO, sold 174,552 shares of Onespaworld Holdings Ltd at $30.51 to $30.85 a share (average $30.72) in 2 transactions, worth $5.36M in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 216,513 (-23.2%).
Omnicom Group Insider Linda Johnson Rice Sells $61.3K of Stock
Linda Johnson Rice sold 697 shares of Omnicom Group Inc. at $87.92 a share, worth $61.3K in total on Nov 12, 2026. Shares held after the trade: 11,824 (-5.6%).
Vulcan Infrastructure & Power Inc. filed its Form 10-Q on November 16, 2026, providing a quarterly update on its financial condition and results of operations. The filing includes condensed consolidated financial statements and management's discussion regarding the company's infrastructure and power project developments.
First Carolina Financial Services, Inc. reported its financial results for the quarter ended September 30, 2026, highlighting continued growth in net interest income and a stable credit profile. The filing emphasizes the company's strategic focus on community banking and maintaining strong capital ratios amidst evolving economic conditions.
Insperity Insider Tim Clifford Sells $260K of Stock
Tim Clifford sold 5,178 shares of Insperity, Inc. at $50.19 a share, worth $260K in total on Nov 13, 2026. Shares held after the trade: 23,935 (-17.8%).
CareDx Director Michael Goldberg Sells $1.09M of Stock
Michael Goldberg, Director, sold 13,800 shares of CareDx, Inc. at $78.32 to $79.85 a share (average $79.15) in 3 transactions, worth $1.09M in total on Nov 12, 2026. Shares held after the trade: 48,526 (-4.4%).
CareDx CFO & COO Keith Kennedy Sells $166K of Stock
Keith Kennedy, CFO & COO, sold 2,097 shares of CareDx, Inc. at $78.78 to $79.61 a share (average $79.29) in 2 transactions, worth $166K in total on Nov 12, 2026. Shares held after the trade: 199,147 (-0.6%).
For the three months ended September 30, 2026, MacKenzie Realty Capital reported a net loss attributable to common stockholders of $4.54 million, or $1.64 per share, compared to a loss of $4.09 million in the prior year period. Total assets increased slightly to $236.99 million, while total equity declined to $75.91 million due to an increasing accumulated deficit and dividend distributions.
Smith-Midland Corporation reported total revenue of $22.8 million for the third quarter of 2026, a slight increase from $21.5 million in the prior year, driven by strong barrier rental growth. However, nine-month net income decreased significantly to $5.7 million compared to $10.4 million in 2025, primarily due to higher operating expenses and lower year-to-date barrier rental revenue.
Brookfield Oaktree Holdings, LLC reported a decrease in corporate investments from $1.43 billion at year-end 2025 to $1.23 billion as of September 30, 2026. The company maintained its status as a non-accelerated filer and reported 118,832,320 Class A units outstanding as of November 16, 2026.
PrimeEnergy Resources Corporation is a non-accelerated filer and smaller reporting company with 1,574,500 shares of common stock outstanding as of November 16, 2026. The filing includes condensed consolidated financial statements for the period ending September 30, 2026, and highlights risks related to commodity price volatility and geopolitical instability.
Firy Inc. reported a net loss of $47.9 million for the nine months ended September 30, 2026, an improvement from the $52.5 million loss in the prior year period. Revenue grew to $91.4 million for the nine months, while the company significantly reduced its debt through an $80 million redemption of senior secured notes.
For the nine months ended September 30, 2026, HireQuest reported total revenue of $23.4 million and net income of $5.9 million, an increase from $4.7 million in the prior year period. The company maintained its dividend at $0.06 per share for the quarter while managing a significant increase in accounts receivable and a reduction in cash to $1.1 million.